Efavirenz - Wikipedia, the free encyclopedia
Efavirenz (brand names Sustiva and Stocrin) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active
antiretroviral ...
http://en.wikipedia.org/wiki/Efavirenz...
|
AIDSinfo - HIV/AIDS Drug Information - Efavirenz
Efavirenz, also known as EFV or Sustiva, is a type of medicine called a non- nucleoside reverse transcriptase inhibitor (NNRTI). ...
http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?int_i...
|
Pharmacogenetics of plasma efavirenz exposure after treatment ...
BACKGROUND: Efavirenz has a long plasma half-life and a low genetic barrier to resistance. Simultaneously stopping treatment with all agents in ...
http://www.ncbi.nlm.nih.gov/pubmed/16392089...
|
AIDSinfo - HIV/AIDS Drug Information - Efavirenz / Emtricitabine ...
Efavirenz is a type of medicine called a non-nucleoside reverse transcriptase inhibitor (NNRTI). Both emtricitabine and tenofovir DF are medicines called ...
http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailNT.aspx?int_i...
|
Efavirenz detectable in plasma 8 weeks after stopping therapy and ...
1: AIDS. 2005 Oct 14;19(15):1716-7. Efavirenz detectable in plasma 8 weeks after stopping therapy and subsequent development of non-nucleoside reverse ...
http://www.ncbi.nlm.nih.gov/pubmed/16184054...
|
Efavirenz: MedlinePlus Drug Information
Efavirenz is used with other medications to treat human immunodeficiency virus ( HIV) infection in patients with or without acquired immunodeficiency ...
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a699004.htm...
|
Triple-nucleoside regimens versus efavirenz-containing regimens ...
After a median follow-up of 32 weeks, 82 of 382 subjects in the triple- nucleoside group (21 percent) and 85 of 765 of those in the combined efavirenz
groups ...
http://www.ncbi.nlm.nih.gov/pubmed/15115831...
|
AIDSinfo - HIV/AIDS Drug Information - Efavirenz / Emtricitabine ...
12 Jul 2006 ... One tablet of Atripla is equivalent to one tablet of efavirenz 600 mg, a non- nucleoside reverse transcriptase inhibitor (NNRTI), ...
http://www.aidsinfo.nih.gov/DrugsNew/DrugDetailT.aspx?int_id...
|
Substitution of nevirapine, efavirenz, or abacavir for protease ...
BACKGROUND: We assessed the strategy of substituting nevirapine, efavirenz, or abacavir for a protease inhibitor in patients infected with human ...
http://www.ncbi.nlm.nih.gov/pubmed/12968087...
|
Resistance to efavirenz (SUSTIVA) in vivo.
Efavirenz (SUSTIVA, DMP 266) is a potent inhibitor of the reverse transcriptase of HIV-1. In order to assess the potential for the development of resistance ...
http://gateway.nlm.nih.gov/MeetingAbstracts/102236281.html...
|
